160
Participants
Start Date
July 1, 2022
Primary Completion Date
December 1, 2026
Study Completion Date
December 1, 2026
ONCOLAXY Follow-up
"The operation of Oncolaxy© is based on the principle of e-PRO (electronic patient reported outcome) which is able to assess the symptoms declared by patients treated for cancer, to detect an evolution, a recurrence or the toxicity of a therapy. Alerts are sent to the healthcare team if the algorithm detects suspicious symptoms or worsening of these symptoms.~Oncolaxy© records symptoms using an electronic questionnaire that allows them to be graded. Questionnaires are sent out on a regular basis. The algorithm analyzes the responses and processes them taking into account the score of the response and its evolution over time. The combination of the results makes it possible to send information to the healthcare teams in charge of the patient that will alert them, enlighten them and help them guide their decisions which remain under their sole control. The summary of the results can be viewed at any time on a dashboard."
Polyclinique Bordeaux Nord Aquitaine, Bordeaux
Hôpital Privée du Confluent, Nantes
Centre Hospitalier de St Nazaire, Saint-Nazaire
Centre de radiothérapie de Robertsau, Strasbourg
Clinique Victor Hugo/Centre Jean Bernard/ILC, Le Mans
Collaborators (2)
Resilience
INDUSTRY
Incyte Corporation
INDUSTRY
Weprom
OTHER